Clever and Personable: Marvel Biosciences Announces Private Placement for Up to $2.5 Million
Marvel Biosciences Corp. Announces Non-Brokered Private Placement CALGARY, ALBERTA–(Newsfile Corp. – January 7, 2025) Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) (“Marvel” or the “Company”) has revealed plans to carry out a non-brokered private placement of common shares of the Company at a rate of $0.15 per Common Share, with anticipated gross proceeds ranging from…